United Therapeutics Corp (UTHR)
233.75
-2.20
(-0.93%)
USD |
NASDAQ |
Apr 26, 16:00
233.75
0.00 (0.00%)
After-Hours: 16:34
United Therapeutics Net Income (TTM): 984.80M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 984.80M |
September 30, 2023 | 899.80M |
June 30, 2023 | 871.50M |
March 31, 2023 | 728.30M |
December 31, 2022 | 727.30M |
September 30, 2022 | 707.40M |
June 30, 2022 | 630.80M |
March 31, 2022 | 687.40M |
December 31, 2021 | 475.80M |
September 30, 2021 | 462.40M |
June 30, 2021 | 470.90M |
March 31, 2021 | 405.40M |
December 31, 2020 | 514.80M |
September 30, 2020 | 468.60M |
June 30, 2020 | 429.80M |
March 31, 2020 | 527.80M |
December 31, 2019 | -104.50M |
September 30, 2019 | -91.80M |
June 30, 2019 | -117.70M |
March 31, 2019 | -149.90M |
December 31, 2018 | 589.20M |
September 30, 2018 | 542.90M |
June 30, 2018 | 712.70M |
March 31, 2018 | 483.80M |
December 31, 2017 | 417.90M |
Date | Value |
---|---|
September 30, 2017 | 509.20M |
June 30, 2017 | 394.70M |
March 31, 2017 | 656.80M |
December 31, 2016 | 713.70M |
September 30, 2016 | 708.00M |
June 30, 2016 | 1.011B |
March 31, 2016 | 903.70M |
December 31, 2015 | 651.60M |
September 30, 2015 | 662.96M |
June 30, 2015 | 173.32M |
March 31, 2015 | 185.98M |
December 31, 2014 | 340.10M |
September 30, 2014 | 193.82M |
June 30, 2014 | 281.75M |
March 31, 2014 | 249.76M |
December 31, 2013 | 174.56M |
September 30, 2013 | 288.13M |
June 30, 2013 | 303.56M |
March 31, 2013 | 296.01M |
December 31, 2012 | 304.44M |
September 30, 2012 | 264.38M |
June 30, 2012 | 270.66M |
March 31, 2012 | 272.24M |
December 31, 2011 | 217.87M |
September 30, 2011 | 184.22M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-117.70M
Minimum
Jun 2019
984.80M
Maximum
Dec 2023
509.41M
Average
514.80M
Median
Dec 2020
Net Income (TTM) Benchmarks
Liquidia Corp | -78.50M |
Esperion Therapeutics Inc | -209.25M |
Vertex Pharmaceuticals Inc | 3.620B |
Heron Therapeutics Inc | -110.56M |
Aldeyra Therapeutics Inc | -37.54M |